Skip to main content

Table 1 Demographic, Vocation, Medication and Treatment Information of Participants

From: Subjective experiences of neurocognitive functioning in young people with major depression

Participant

Current vocation

Current mental health medication

Self-reported treatment length

Self-reported age of depression onset

P1

Tertiary study

Fluoxetine (80 mg)

1 year

11–12 years

P2

School (Year 12)

Fluoxetine (20 mg)

5 months

12–13 years

P3

Tertiary study

Pristiq

11 months

16 years

P4

Tertiary study and work

Sertraline (100 mg)

5 months

12 years

P5

Not currently working or studying

Antidepressant - couldn’t recall name

7 months

15 years

P6

Work

Mood stabiliser – couldn’t recall name.

4 months

22 years

P7

Tertiary study, about to commence work

Fluoxetine (25 mg)

3 months

15 years

P8

Tertiary study

Sertraline (200 mg)

4 months

15 years

P9

Not currently working or studying

Fluoxetine (40 mg)

2 months

14 years

P10

Not currently working or studying

Fluoxetine

12 months

12 years

P11

Tertiary study

Escitalopram (20 mg), Mirtazapine (7.5 mg)

6 months

14 years